Sarita Nori is a Dermatology physician affiliated with Harvard Vanguard Medical Associates. OpenAlex indexes 5 publications with 428 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Maple St
Kuchnir Dermatology
Milford, MA 01757
Telephone
508-478-2610Provider last certified this registry record 22 Jul 2024.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202527 payments$17,576openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year202510 payments
- Incyte CorporationProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
26%Corticosteroid15.8%Triamcinolone Acetonide100%Part D≥138 patientsInterleukin-4 Receptor alpha Antagonist3.6%Dupixent Pen100%Part D<11 patients+ 3 more classes in this area
Anti-infectives
25.1%Azole Antifungal11%Ketoconazole100%Part D≥61 patientsTetracycline-class Drug4.7%Doxycycline Monohydrate57%Doxycycline Hyclate43%Part D≥27 patients+ 3 more classes in this area
Sensory organs
16.6%Corticosteroid16.6%Betamethasone Dipropionate54%Betamethasone Diprop Augmented29%Clobetasol Propionate10%Hydrocortisone8%Part D≥67 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 74985 AI Visualization and Severity Analysis Decreases Patient Distress and Anxiety While Patient Perception of AI Remains Unchanged
Journal of the American Academy of Dermatology
2026 - Infectious occupational exposures in dermatology–A review of risks and prevention measures
Journal of the American Academy of Dermatology
2005 - Infectious occupational exposures in dermatology–A review of risks and prevention measures
Journal of the American Academy of Dermatology
2005 - Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: A multicenter study
Journal of the American Academy of Dermatology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”